SRx Health Solutions, Inc. 8-K

What Happened

• On June 18, 2026, SRx Health Solutions, Inc. (NYSE: SRXH) announced it closed the previously disclosed Share Exchange and Asset Transfer Agreement and acquired 100% of EMJ Crypto Technologies Inc. (EMJC) and CCC Crypto Corp., plus a 100% direct and indirect ownership interest in the related IP Asset. At closing the company issued an aggregate of 268,346,659 shares of common stock, 117,268,196 exchangeable shares of a new subsidiary (exchangeable one-for-one into common stock), and Pre-Funded Warrants to purchase 44,368,530 shares. The securities issued and issuable were registered in a Form S-4 (File No. 333-295154) declared effective May 7, 2026. The company also announced an immediate legal name change to SRX Global Inc.; the stock will continue trading under the ticker SRXH (and the existing name) for 10 business days after the press release.

Key Details

• Closing date: June 18, 2026; original agreement dated December 16, 2025 (amended March 11 and June 17, 2026).
• Acquisition: 100% of EMJ Crypto Technologies Inc. and CCC Crypto Corp., plus the IP Asset defined in the transfer agreement.
• Consideration issued: 268,346,659 common shares; 117,268,196 exchangeable shares (1-for-1 exchangeable into common); 44,368,530 Pre-Funded Warrants.
• Registration: Shares issued and issuable registered under the Securities Act via Form S-4 effective May 7, 2026. Press release was furnished under Regulation FD (not “filed” for Section 18 liability).

Why It Matters

• This is a material acquisition and change of direction: the company now owns the acquired crypto businesses and related IP, which may materially affect its business mix.
• The transaction involved a large issuance of equity and warrants (hundreds of millions of shares and tens of millions of warrants/exchangeable shares), which increases the company’s outstanding potential share count and can affect existing shareholder ownership percentages.
• The legal name change to SRX Global Inc. signals a rebranding tied to the transaction; trading will remain on NYSE under SRXH in the short term.
• Investors should review the company’s Form S-4 and the press release for full transaction terms and consult SEC filings for further financial details.